help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on April 3, 2008
Endocrinology, doi:10.1210/en.2008-0143
A more recent version of this article appeared on July 1, 2008
This Article
Right arrow Author Manuscript (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
149/7/3294    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kamenicky, P.
Right arrow Articles by Lombès, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kamenicky, P.
Right arrow Articles by Lombès, M.

Submitted on January 30, 2008
Accepted on March 21, 2008

Epithelial Sodium Channel Is a Key Mediator of Growth Hormone–Induced Sodium Retention in Acromegaly

Peter Kamenicky, Say Viengchareun, Anne Blanchard, Geri Meduri, Philippe Zizzari, Martine Imbert-Teboul, Alain Doucet, Philippe Chanson, and Marc Lombès*

Inserm, U693, Le Kremlin Bicêtre, F-94276, France; Univ Paris-Sud 11, Faculté de Médecine Paris-Sud, UMR-S693, Le Kremlin Bicêtre, F-94276, France; Assistance Publique-Hôpitaux de Paris, Hôpital Européen Georges Pompidou, Centre d'Investigation Clinique, F-75908, Paris, France; Assistance Publique-Hôpitaux de Paris, Hôpital de Bicêtre, Service de Pharmacogénétique, Biochimie Moléculaire et Hormonologie, Le Kremlin Bicêtre, F-94275, France; Inserm, U549, Centre Broca, Paris, F-75014, France; CNRS/UPMC, UMR7134, Institut des Cordeliers, Paris, F-75006, France; Assistance Publique-Hôpitaux de Paris, Hôpital de Bicêtre, Service d'Endocrinologie et Maladies de la Reproduction, Le Kremlin Bicêtre, F-94275, France

* To whom correspondence should be addressed. E-mail: marc.lombes{at}u-psud.fr.

Acromegalic patients present with volume expansion and arterial hypertension but the renal sites and molecular mechanisms of direct antinatriuretic action of growth hormone (GH) remain unclear. Here, we show that acromegalic GC rats, which are chronically exposed to very high levels of GH, exhibited a decrease of furosemide-induced natriuresis and an increase of amiloride-stimulated natriuresis compared to controls. Enhanced Na+, K+-ATPase activity and altered proteolytic maturation of epithelial sodium channel (ENaC) subunits in the cortical collecting ducts (CCD) of GC rats provided additional evidence for an increased sodium reabsorption in the late distal nephron under chronic GH excess. In vitro experiments on KC3AC1 cells, a murine CCD cell model revealed the expression of functional GH receptors (GHR) and IGF-1 receptors coupled to activation of JAK2/STAT5, ERK and AKT signaling pathways. That GH directly controls sodium reabsorption in CCD cells is supported by i) stimulation of transepithelial sodium transport inhibited by GHR antagonist pegvisomant ii) induction of {alpha}ENaC mRNA expression iii) identification of STAT5 binding to a response element located in the {alpha}ENaC promoter, indicative of the transcriptional regulation of {alpha}ENaC by GH. Our findings provide first evidence that GH, in concert with IGF-1, stimulates ENaC-mediated sodium transport in the late distal nephron, accounting for the pathogenesis of sodium retention in acromegaly.


Key words: growth hormone • kidney • sodium homeostasis • acromegaly







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2008 by The Endocrine Society